H J Harkins Company Inc dba Pharma Pac is recalling approximately 7,212 bottles of Ranitidine (generic Zantac) 150 mg tablets because testing detected the presence of N-Nitrosodimethylamine (NDMA). This impurity is a substance that could cause cancer and was found in products sold in multiple bottle sizes including 7, 14, 20, 30, and 60-count containers. These prescription-only medications were distributed primarily to physicians in California, Florida, North Carolina, and South Carolina between 2020 and 2021.
The tablets contain NDMA, a probable human carcinogen. Long-term exposure to levels of this impurity above acceptable limits may increase the risk of developing cancer.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.